Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision

Cibus, Inc. (NASDAQ:CBUS) is one of the 10 Fastest Growing Tech Penny Stocks to Buy.

On June 17, 2026, Cibus, Inc. (NASDAQ:CBUS) welcomed a landmark European Union decision under which crops improved without adding foreign DNA will be treated like conventionally bred crops rather than transgenic GMOs. Cibus said the decision opens a path for European farmers to grow cleaner crops more productively, including by fighting disease and pests with fewer chemicals.

Cibus said the new rules draw a line between transgenic GMOs, which add foreign DNA, and the precise, non-transgenic improvements Cibus makes to a plant’s own genes. The company said crops that resist disease, use water and nutrients more efficiently, and require fewer chemicals qualify for the framework’s non-GMO fast lane, where they are treated the same as conventionally bred crops. President and COO Peter Beetham said the E.U. completed a “science-based review” and recognized that crops with changes that could occur in nature or through traditional breeding should be regulated accordingly.

On June 9, Cibus announced leadership changes under its previously announced succession planning strategy. Craig Wichner, a board member since November 2025, was appointed CEO. Peter Beetham, who served as Interim CEO, will continue as President and COO. Wichner and Beetham also resigned from the Cibus Board of Directors as part of the reorganization and plan.

Cibus, Inc. (NASDAQ:CBUS) is an agricultural biotechnology company that develops and licenses gene-edited plant traits.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.